GPC3 and hepatocellular carcinoma: The two clinically utilized human HCC markers Alpha-fetoprotein (Afp) and Glypican-3 (Gpc3) were upregulated in both WT and MPC LivKO tumors, providing evidence of similarity to human HCC (Masuzaki et al., 2012).